Evidence map›Paper›PMID 34949838›Full record

ArticleNature chemical biology2022

Precise genome editing across kingdoms of life using retron-derived DNA.

Santiago C Lopez, Kate D Crawford, Sierra K Lear, Santi Bhattarai-Kline, Seth L Shipman

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Structure and mechanism of antiphage retron Eco2.Nature structural & molecular biology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Santiago C LopezGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Kate D CrawfordGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Sierra K LearGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-7410-9688
Santi Bhattarai-KlineGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Seth L ShipmanGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA. seth.shipman@gladstone.ucsf.edu.ORCID http://orcid.org/0000-0003-3130-8043
Gladstone Institutes · US

Funding

Engineered Mitochondria for Therapeutic Donation and Mitochondrial Genome EditingDP2GM140917 · NIGMS · J. DAVID GLADSTONE INSTITUTES · PI SHIPMAN, SETH LAWLER · 2020 to 2020
$2.8M
NIGMS NIH HHS DP2 GM140917
6 · The paper itself

Abstract

Exogenous DNA can be a template to precisely edit a cell's genome. However, the delivery of in vitro-produced DNA to target cells can be inefficient, and low abundance of template DNA may underlie the low rate of precise editing. One potential tool to produce template DNA inside cells is a retron, a bacterial retroelement involved in phage defense. However, little effort has been directed at optimizing retrons to produce designed sequences. Here, we identify modifications to the retron non-coding RNA (ncRNA) that result in more abundant reverse-transcribed DNA (RT-DNA). By testing architectures of the retron operon that enable efficient reverse transcription, we find that gains in DNA production are portable from prokaryotic to eukaryotic cells and result in more efficient genome editing. Finally, we show that retron RT-DNA can be used to precisely edit cultured human cells. These experiments provide a general framework to produce DNA using retrons for genome modification.

Indexed as

AnimalsDNAEscherichia coliGene EditingGene Expression RegulationGene LibraryHEK293 CellsHumansRetroelementsRNA, BacterialRNA, Long NoncodingSaccharomyces cerevisiaeDNARetroelementsRNA, BacterialRNA, Long Noncoding

Identifiers

PMID34949838
PMCPMC8810715
OpenAlexW4200471576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.